Table 1.
Protocol | Viraemia | Immune Response | Reference | |||
---|---|---|---|---|---|---|
Test | Detection Period | Peak Value | Test | Antibody Detection | ||
5 sows, IV inoculation, Kanagawa strain, bled daily | ICISM | 1–4 dpi | NA | VN in mice | >7 dpi | [51] |
4 piglets, SC inoculation, M5/596 and pig9 strains, bled daily | ICISM | For 4 days | 2.6 log LD50/0.03 mL | HIA | 7–35 * dpi | [47] |
2 piglets, SC inoculation, 9215 strain, bled daily | ICISM | 1–4 dpi | NA | HIA | All positive at 7 dpi | [52] |
6 piglets, SC inoculation, Nakayama strain, bled daily | ICISM + RT-PCR | 2–5 dpi | NA | SNT | All positive at 14 dpi | [53] |
12 piglets, IV + ID inoculation, Nakayama strain, bled daily | RT-PCR | 1–5 dpi | 10^4 U/mL ** | SNT | 3–11 * dpi | [22] |
10 piglets, IV inoculation, JE-91 strain, bled daily | RT-PCR | 3–5 dpi | 10^3.5 U/mL ** | SNT | All positive at 28 dpi | [54] |
IV—intravenous; SC—subcutaneous; ID—intradermal; LD50—50% lethal dose; TCID50—50% tissue culture infective dose; ICISM—intracerebral inoculation of suckling mice; RT-PCR—reverse transcription-polymerase chain reaction; VN—virus neutralization; HIA—hemagglutination inhibition assay; SNT—seroneutralization test; dpi—day post-infection; *All piglets positive at the date when monitoring ended; ** One U was defined as the viral RNA quantity corresponding to 1 TCID50 of the virus preparation used as the standard by the authors; NA: non-applicable, when viraemia detection was qualitative.